PKC? phosphorylates TRAF2 to protect against intestinal ischemia-reperfusion-induced injury.
Ontology highlight
ABSTRACT: Intestinal ischemia-reperfusion (I/R) is a common clinical problem that occurs during various clinical pathological processes. Excessive apoptosis has an indispensable role in intestinal I/R injury. Tumor necrosis factor receptor-associated factor 2 (TRAF2) and PKC? have an essential role in apoptosis. Here, we aimed to investigate the effects of PKC? and TRAF2 and to explore the correlation between PKC? and TRAF2 in intestinal I/R injury. Mice were subjected to intestinal I/R injury in vivo. In vitro experiments were conducted by treating Caco-2 cells with hypoxia/reoxygenation (H/R) stimulation to simulate intestinal I/R. Intestinal tissue samples and Caco-2 cells were examined using various approaches. Intestinal I/R induced the membrane translocation and phosphorylation of PKC?. Pretreatment with the PKC? activator phosphatidylcholine remarkably attenuated gut injury by suppressing apoptosis. H/R induced PKC? to combine with TRAF2, which was phosphorylated by PKC? at Ser55, but not at Ser11, under intestinal I/R or H/R conditions. In addition, TRAF2 Ser55 phosphorylation increased cell survival by inhibiting cell apoptosis in the H/R model. Mechanistically, TRAF2 Ser55 phosphorylation promoted NF-?B activation but suppressed c-Jun activation in Caco-2 cells under H/R conditions. The results of this study demonstrate that the PKC?/TRAF2 pathway represents a novel protective mechanism against intestinal I/R injury. Therefore, the PKC?/TRAF2 pathway is a novel target for potential treatments of intestinal I/R injury-related diseases.
SUBMITTER: Zhou W
PROVIDER: S-EPMC5550857 | biostudies-other | 2017 Jul
REPOSITORIES: biostudies-other
ACCESS DATA